Director & President, R&D
Director & President, R&D at Krystal Biotech, Inc., filing insider transactions on 2026-09-04.
| SEC ↗ |
| 2026-09-04 | KRYS | Sale | 2,006 | $355.57 | $713K | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 2,320 | $360.47 | $836K | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 3,180 | $358.42 | $1.1M | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 3,267 | $356.37 | $1.2M | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 3,392 | $359.39 | $1.2M | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 3,962 | $357.57 | $1.4M | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 399 | $366.56 | $146K | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 520 | $354.54 | $184K | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 565 | $363.34 | $205K | SEC ↗ |
| 2026-09-04 | KRYS | Sale | 826 | $365.41 | $302K | SEC ↗ |